OrphAI Therapeutics specializes in pioneering treatments for various diseases, focusing on conditions such as pulmonary hypertension, Bronchiolitis Obliterans Syndrome post lung transplant, and oncology. The company is at the forefront of integrating advanced biotechnological solutions within the healthcare industry to improve patient outcomes.